NPI: 1346233277 · GREENSBORO, NC 27410 · Clinical Medical Laboratory · NPI assigned 08/25/2005
Authorized official BOWLES, CHARLES controls 20+ related entities in our dataset. Read more
| Authorized Official | BOWLES, CHARLES (VICE PRESIDENT) |
| Parent Organization | QUEST DIAGNOSTICS INCORPORATED |
| NPI Enumeration Date | 08/25/2005 |
Other providers sharing the same authorized official: BOWLES, CHARLES
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 880,843 | $7.98M |
| 2019 | 351,375 | $3.64M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 32,767 | 28,837 | $709K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 32,355 | 28,487 | $696K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 30,984 | 27,927 | $614K |
| 80061 | Lipid panel | 69,225 | 62,995 | $600K |
| 84443 | Thyroid stimulating hormone (TSH) | 51,385 | 47,192 | $540K |
| 80053 | Comprehensive metabolic panel | 88,908 | 79,555 | $482K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 19,772 | 17,486 | $391K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 69,660 | 61,170 | $343K |
| 86003 | 5,027 | 3,752 | $339K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 47,977 | 43,653 | $300K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 42,726 | 38,444 | $266K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 12,292 | 10,093 | $254K |
| 80050 | General health panel | 22,107 | 20,320 | $229K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 6,678 | 4,632 | $228K |
| 86480 | 4,814 | 4,448 | $175K | |
| 80074 | 5,508 | 4,597 | $146K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 823 | 779 | $145K |
| 84439 | 21,038 | 19,310 | $139K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 7,746 | 6,306 | $136K |
| 87081 | 23,270 | 21,840 | $130K | |
| 87088 | 20,145 | 18,188 | $127K | |
| 82607 | 12,889 | 11,427 | $119K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 5,378 | 4,825 | $103K |
| 86803 | 9,711 | 8,719 | $97K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3,022 | 2,076 | $94K |
| 87070 | 11,940 | 11,027 | $92K | |
| 80055 | 3,703 | 3,528 | $90K | |
| 85027 | 24,255 | 20,955 | $90K | |
| 87186 | 14,128 | 12,871 | $88K | |
| 82728 | 9,116 | 8,332 | $84K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 21,607 | 17,315 | $82K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 3,404 | 2,633 | $78K |
| 88142 | 4,653 | 3,774 | $76K | |
| 86787 | 5,583 | 5,006 | $72K | |
| 86336 | 1,537 | 1,441 | $71K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 264 | 248 | $68K |
| 87660 | 4,099 | 3,531 | $67K | |
| 86235 | 1,314 | 1,150 | $66K | |
| 82746 | 6,726 | 6,047 | $65K | |
| 84481 | 4,715 | 4,349 | $65K | |
| 87077 | 10,612 | 9,437 | $62K | |
| 83013 | 1,150 | 1,094 | $61K | |
| 87510 | 4,106 | 3,539 | $60K | |
| 86850 | 5,282 | 4,957 | $58K | |
| 83970 | 3,536 | 3,120 | $57K | |
| 84153 | 4,976 | 4,470 | $54K | |
| 86360 | 1,760 | 1,696 | $54K | |
| 80081 | 1,455 | 1,290 | $53K | |
| 84146 | 3,177 | 2,958 | $51K | |
| 84436 | 12,745 | 11,506 | $49K | |
| 86592 | 13,876 | 12,226 | $48K | |
| 86008 | 646 | 594 | $47K | |
| 83550 | 8,569 | 7,754 | $46K | |
| 84479 | 10,666 | 9,618 | $44K | |
| 84702 | 5,538 | 4,469 | $42K | |
| 83540 | 10,095 | 9,129 | $42K | |
| 87150 | 1,656 | 1,578 | $42K | |
| 86696 | 3,253 | 2,461 | $41K | |
| 86038 | 5,247 | 4,702 | $40K | |
| 82105 | 3,143 | 2,894 | $40K | |
| 87799 | 856 | 615 | $40K | |
| 87340 | 5,183 | 4,714 | $39K | |
| 82785 | 2,504 | 2,365 | $38K | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 871 | 746 | $38K |
| APT16 | 2,823 | 2,822 | $38K | |
| 84403 | 2,225 | 1,991 | $37K | |
| 83001 | 2,549 | 2,330 | $37K | |
| 83880 | 2,719 | 2,180 | $37K | |
| 82677 | 1,651 | 1,551 | $36K | |
| 86361 | 2,971 | 2,758 | $36K | |
| 82570 | 11,966 | 10,630 | $34K | |
| 80164 | 4,140 | 3,712 | $33K | |
| 87902 | 320 | 266 | $32K | |
| 83718 | 3,190 | 3,175 | $32K | |
| 83002 | 2,078 | 1,885 | $31K | |
| 87147 | 6,303 | 5,866 | $31K | |
| 83516 | 3,945 | 2,638 | $30K | |
| 82043 | 9,635 | 8,892 | $30K | |
| 83525 | 2,716 | 2,541 | $29K | |
| 80076 | 5,185 | 4,704 | $29K | |
| 86140 | 7,627 | 6,737 | $28K | |
| 87522 | Neg quan hep c or qual rna | 1,729 | 1,478 | $28K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 717 | 660 | $28K |
| 83735 | 7,503 | 6,160 | $27K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,218 | 1,155 | $27K |
| 82784 | 2,808 | 2,531 | $26K | |
| 82670 | 1,411 | 1,259 | $26K | |
| 83655 | 2,710 | 2,641 | $24K | |
| 87650 | 1,332 | 1,231 | $23K | |
| 86762 | 1,890 | 1,782 | $23K | |
| 86665 | 1,953 | 1,226 | $23K | |
| 86695 | 2,635 | 1,965 | $22K | |
| 86376 | 2,090 | 1,920 | $21K | |
| 87209 | 1,361 | 1,204 | $20K | |
| 85652 | 9,683 | 8,607 | $20K | |
| 87480 | 4,101 | 3,531 | $19K | |
| 36415 | Collection of venous blood by venipuncture | 53,753 | 43,285 | $17K |
| 86160 | 1,189 | 1,083 | $17K | |
| 81001 | 8,774 | 7,884 | $17K | |
| 83690 | 3,551 | 3,040 | $16K | |
| 88141 | 4,288 | 3,107 | $16K | |
| 84550 | 6,927 | 6,207 | $16K | |
| 86664 | 1,282 | 1,177 | $16K | |
| 86147 | 695 | 468 | $16K | |
| 86431 | 4,152 | 3,755 | $16K | |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 36 | 29 | $15K |
| 84144 | 1,072 | 848 | $15K | |
| 84480 | 2,139 | 1,887 | $15K | |
| 87512 | 594 | 553 | $15K | |
| 82950 | 3,399 | 3,197 | $14K | |
| 86706 | 2,229 | 2,002 | $14K | |
| 86800 | 1,204 | 1,128 | $14K | |
| 85610 | 7,552 | 4,633 | $14K | |
| 87046 | 1,915 | 1,641 | $14K | |
| 87427 | 1,444 | 1,342 | $14K | |
| 86901 | 4,393 | 4,119 | $13K | |
| 86900 | 4,391 | 4,117 | $13K | |
| 87205 | 4,005 | 3,631 | $13K | |
| 86200 | 1,720 | 1,567 | $13K | |
| 86225 | 1,487 | 1,358 | $12K | |
| 82248 | 4,756 | 4,175 | $12K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 184 | 169 | $12K |
| 82150 | 2,659 | 2,253 | $12K | |
| 87045 | 1,730 | 1,614 | $11K | |
| 82627 | 670 | 614 | $11K | |
| 85660 | 1,943 | 1,858 | $11K | |
| 80348 | 1,486 | 643 | $11K | |
| 87075 | 1,514 | 1,390 | $11K | |
| 87177 | 1,671 | 1,485 | $11K | |
| 86704 | 1,828 | 1,624 | $11K | |
| 82951 | 959 | 909 | $10K | |
| 86708 | 1,211 | 1,097 | $10K | |
| 84270 | 675 | 612 | $10K | |
| 80069 | 3,267 | 2,780 | $10K | |
| 83021 | 680 | 643 | $10K | |
| 82140 | 1,228 | 1,016 | $10K | |
| 86618 | 782 | 731 | $9K | |
| 87536 | 288 | 270 | $9K | |
| 82550 | 2,189 | 1,974 | $9K | |
| 87255 | 403 | 378 | $9K | |
| 82274 | 855 | 773 | $9K | |
| 84156 | 4,326 | 3,776 | $9K | |
| 83630 | 644 | 591 | $8K | |
| 86355 | 450 | 433 | $8K | |
| 86039 | 1,200 | 1,088 | $8K | |
| 80185 | 1,208 | 981 | $8K | |
| 82533 | 657 | 591 | $7K | |
| 80178 | 1,584 | 1,405 | $7K | |
| 87449 | 1,157 | 1,050 | $7K | |
| 84681 | 609 | 552 | $7K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 186 | 156 | $7K |
| 87324 | 1,132 | 1,029 | $7K | |
| 86357 | 396 | 382 | $7K | |
| 86359 | 497 | 480 | $7K | |
| 85045 | 2,331 | 2,147 | $7K | |
| 87338 | 763 | 687 | $7K | |
| 82977 | 1,426 | 1,290 | $7K | |
| 86146 | 216 | 157 | $6K | |
| 83520 | 845 | 768 | $6K | |
| 82947 | 2,330 | 2,109 | $6K | |
| 87631 | 75 | 75 | $6K | |
| 86317 | 626 | 416 | $6K | |
| 84703 | 1,040 | 921 | $6K | |
| 86021 | 933 | 682 | $6K | |
| 86141 | 900 | 769 | $6K | |
| 85379 | 885 | 802 | $6K | |
| 83615 | 1,439 | 1,243 | $5K | |
| 84154 | 440 | 393 | $5K | |
| 86757 | 414 | 345 | $5K | |
| 86255 | 582 | 518 | $5K | |
| 85060 | 461 | 431 | $5K | |
| 80156 | 765 | 686 | $5K | |
| 84100 | 3,109 | 2,531 | $5K | |
| 81025 | 651 | 609 | $5K | |
| 82565 | 1,762 | 1,534 | $4K | |
| 82247 | 1,233 | 904 | $4K | |
| 86780 | 459 | 399 | $4K | |
| 85730 | 1,261 | 1,106 | $4K | |
| 86777 | 357 | 323 | $4K | |
| 82378 | 413 | 354 | $4K | |
| 87493 | 224 | 211 | $4K | |
| 84466 | 588 | 537 | $4K | |
| 86778 | 273 | 256 | $4K | |
| 82465 | 1,016 | 901 | $4K | |
| 86334 | 350 | 316 | $4K | |
| 87329 | 413 | 388 | $4K | |
| 87899 | 537 | 264 | $4K | |
| 84450 | 1,662 | 1,473 | $3K | |
| 80346 | 310 | 216 | $3K | |
| 83090 | 417 | 344 | $3K | |
| 85018 | 2,393 | 2,122 | $3K | |
| 84165 | 497 | 458 | $3K | |
| 82952 | 930 | 855 | $3K | |
| 84484 | 454 | 418 | $3K | |
| 87040 | 439 | 325 | $3K | |
| 84402 | 228 | 205 | $3K | |
| 84432 | 206 | 199 | $3K | |
| 86705 | 521 | 468 | $3K | |
| 88112 | 88 | 70 | $3K | |
| 83721 | 689 | 645 | $3K | |
| 81003 | 2,070 | 1,885 | $2K | |
| 84134 | 344 | 290 | $2K | |
| 80361 | 252 | 205 | $2K | |
| 82652 | 201 | 173 | $2K | |
| 80197 | 544 | 392 | $2K | |
| 83704 | 286 | 245 | $2K | |
| 83883 | 315 | 255 | $2K | |
| APT15 | 211 | 208 | $2K | |
| 87481 | 171 | 64 | $2K | |
| 88342 | 133 | 99 | $2K | |
| 80202 | 316 | 123 | $2K | |
| 86304 | 198 | 175 | $2K | |
| 86644 | 193 | 180 | $2K | |
| 86663 | 202 | 188 | $2K | |
| 86645 | 173 | 162 | $2K | |
| 82310 | 1,356 | 1,238 | $2K | |
| 85014 | 1,507 | 1,303 | $2K | |
| 80349 | 234 | 145 | $2K | |
| 86735 | 214 | 198 | $2K | |
| 83631 | 127 | 121 | $2K | |
| 88312 | 39 | 30 | $2K | |
| 84460 | 1,787 | 1,585 | $2K | |
| 80177 | 352 | 304 | $2K | |
| 0001M | 136 | 121 | $2K | |
| 87807 | 131 | 125 | $2K | |
| 80324 | 212 | 123 | $2K | |
| 81015 | 604 | 556 | $2K | |
| 81511 | 121 | 111 | $2K | |
| 84520 | 593 | 472 | $2K | |
| 86765 | 199 | 186 | $1K | |
| 86870 | 61 | 56 | $1K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 63 | 63 | $1K |
| 86308 | 334 | 306 | $1K | |
| 82040 | 686 | 605 | $1K | |
| 83010 | 218 | 199 | $1K | |
| 82955 | 301 | 279 | $1K | |
| 82330 | 216 | 196 | $1K | |
| 80162 | 349 | 302 | $1K | |
| 82610 | 502 | 414 | $1K | |
| 86812 | 55 | 54 | $1K | |
| 88341 | 40 | 30 | $1K | |
| 86709 | 175 | 162 | $1K | |
| 82747 | 110 | 98 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 181 | 150 | $1K |
| 83698 | 277 | 239 | $1K | |
| 84163 | 107 | 105 | $1K | |
| 84132 | 590 | 498 | $1K | |
| 80051 | 204 | 192 | $1K | |
| 86593 | 274 | 237 | $1K | |
| 88304 | 61 | 51 | $1K | |
| 82172 | 320 | 283 | $1K | |
| 81241 | 44 | 41 | $997.75 | |
| 84425 | 162 | 144 | $944.53 | |
| 80175 | 126 | 118 | $940.47 | |
| 83921 | 103 | 98 | $857.80 | |
| 84166 | 87 | 81 | $849.42 | |
| 87210 | 298 | 257 | $835.58 | |
| 82164 | 85 | 84 | $834.30 | |
| 84155 | 574 | 523 | $829.15 | |
| 86300 | 108 | 95 | $812.99 | |
| 83695 | 336 | 285 | $801.90 | |
| 82103 | 121 | 111 | $779.88 | |
| 80365 | 102 | 87 | $748.65 | |
| 82024 | 32 | 26 | $686.91 | |
| 84445 | 42 | 42 | $644.03 | |
| 81374 | 17 | 15 | $616.72 | |
| 86738 | 68 | 63 | $598.35 | |
| 84478 | 212 | 188 | $593.10 | |
| 82390 | 115 | 104 | $577.79 | |
| 86301 | 44 | 32 | $542.38 | |
| 87486 | 32 | 28 | $495.84 | |
| 87581 | 32 | 28 | $495.84 | |
| 86617 | 73 | 58 | $495.63 | |
| 83519 | 45 | 43 | $490.09 | |
| 87015 | 222 | 209 | $457.75 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 911 | 696 | $451.41 |
| 80184 | 86 | 75 | $449.82 | |
| 84305 | 36 | 36 | $439.35 | |
| 80159 | 42 | 24 | $413.85 | |
| 84075 | 408 | 362 | $413.71 | |
| 85613 | 70 | 65 | $406.29 | |
| 85041 | 255 | 244 | $371.13 | |
| 86886 | 57 | 53 | $304.01 | |
| 81240 | 15 | 13 | $302.86 | |
| 82553 | 41 | 38 | $288.51 | |
| 80353 | 73 | 53 | $273.69 | |
| 87625 | 14 | 13 | $264.05 | |
| 89055 | 72 | 70 | $247.46 | |
| 87140 | 38 | 37 | $243.46 | |
| 81000 | 885 | 714 | $240.90 | |
| 87185 | 65 | 57 | $232.12 | |
| 82672 | 19 | 18 | $228.94 | |
| 85048 | 111 | 106 | $217.31 | |
| 85004 | 353 | 338 | $204.22 | |
| 84295 | 147 | 136 | $198.23 | |
| 85651 | 64 | 52 | $197.42 | |
| 87328 | 27 | 27 | $197.30 | |
| 87272 | 14 | 14 | $186.44 | |
| 85240 | 15 | 15 | $186.01 | |
| 84300 | 51 | 45 | $171.49 | |
| 82525 | 26 | 24 | $170.27 | |
| 85007 | 81 | 71 | $157.40 | |
| 80356 | 33 | 33 | $147.23 | |
| 82239 | 13 | 13 | $142.40 | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 134 | 105 | $137.07 |
| 36416 | 784 | 698 | $136.85 | |
| 87425 | 15 | 14 | $128.22 | |
| 83935 | 28 | 26 | $127.60 | |
| 80373 | 32 | 32 | $124.32 | |
| 80320 | 32 | 32 | $121.18 | |
| 80360 | 31 | 31 | $116.41 | |
| 80372 | 30 | 30 | $112.97 | |
| 80354 | 30 | 30 | $112.97 | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 110 | 103 | $112.70 |
| 85300 | 14 | 13 | $109.85 | |
| 82340 | 27 | 25 | $107.54 | |
| 80345 | 32 | 32 | $97.14 | |
| 86707 | 13 | 12 | $92.06 | |
| 80323 | 30 | 30 | $88.02 | |
| 87206 | 48 | 43 | $87.25 | |
| 84630 | 15 | 14 | $85.23 | |
| 80358 | 35 | 35 | $85.07 | |
| 80357 | 29 | 29 | $83.99 | |
| 80368 | 29 | 29 | $83.99 | |
| 80359 | 29 | 29 | $83.99 | |
| 80366 | 29 | 29 | $83.99 | |
| 80355 | 29 | 29 | $83.99 | |
| 80321 | 29 | 29 | $83.99 | |
| 80367 | 29 | 29 | $83.90 | |
| 80377 | 31 | 31 | $83.90 | |
| 80364 | 29 | 29 | $83.90 | |
| 80333 | 29 | 29 | $83.72 | |
| 80370 | 29 | 29 | $81.39 | |
| 80337 | 30 | 30 | $80.39 | |
| 80326 | 29 | 29 | $79.55 | |
| 82575 | 18 | 16 | $75.10 | |
| 80338 | 30 | 30 | $72.56 | |
| 80344 | 30 | 30 | $72.56 | |
| 80299 | 14 | 12 | $71.98 | |
| 82104 | 14 | 14 | $64.10 | |
| 86001 | 13 | 12 | $53.01 | |
| 85046 | 14 | 14 | $47.12 | |
| 83992 | 34 | 32 | $43.82 | |
| 80330 | 29 | 29 | $28.79 | |
| 80340 | 30 | 30 | $24.92 | |
| G0306 | Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count | 90 | 88 | $20.75 |
| G0307 | Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count) | 77 | 76 | $3.55 |
| 82435 | 12 | 12 | $0.00 | |
| G0475 | Hiv antigen/antibody, combination assay, screening | 14 | 12 | $0.00 |
| 87999 | 29 | 29 | $0.00 |